Search results
AstraZeneca’s trial of Imfinzi for lung cancer failed to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 hours agoUK-based pharmaceutical company AstraZeneca has reported high-level results from the ADJUVANT BR.31...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 7 hours agoAstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival in a late-stage trial to treat a type of early-stage lung cancer.
BenevolentAI says second target identified by AstraZeneca collaboration
Proactive Investors· 7 hours agoBenevolentAI (OTC:BAIVF) said that AstraZeneca PLC (LSE:AZN) has identified a target for systemic...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 hours ago0748 GMT – AstraZeneca cancer-drug Imfinzi positive results from bladder-cancer trial outweigh the negative outcome of the treatment’s lung-cancer trial,...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 7 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoWhat do you get when you combine a low share price, an attractive valuation, better growth prospects than meet the eye, and a juicy dividend yield? My...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 7 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...
AstraZeneca (LON:AZN) Given Hold Rating at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 6 days agoDeutsche Bank Aktiengesellschaft reiterated their hold rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to investors on Tuesday, MarketBeat.com ...
AstraZeneca’s Truqap and Faslodex combo receives approval in EU
Pharmaceutical Technology via Yahoo Finance· 4 days agoAstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex...
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 6 days agoAstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did...
